Baird Medical Investment Limited
BDMD | NASDAQ
$0.79
-$0.05 (-6.05%)
Sep 22, 2026, 2:13 PM ET · Market open
Company Profile
Based in China, Baird Medical Investment Holdings Limited and its associated entities specialize in engineering and commercializing microwave ablation medical apparatus. These sophisticated instruments are employed in the minimally invasive management of a diverse array of benign and malignant tumors, notably targeting thyroid nodules, hepatic carcinomas, pulmonary cancers, and mammary lesions. The organization was established in 2012, with its corporate headquarters situated in Guangzhou, China.
Key Executives
| Name | Position |
|---|---|
| Haimei Wu | Chairwoman of the Board of Directors & Chief Executive Officer |
| Mark S. Saxton | Chief Executive Officer U.S. Subsidiary |
| Jie Li | Acting Chief Financial Officer |
| Rongjian Lu | Chief Technology Officer & Deputy GM |
| Quan Qiu | Chief Administrative Officer & Executive Director |
| Wei Hou | Executive Director |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Sep 03, 2026 | 6-K | Filing |
| Aug 18, 2026 | 424B3 | Filing |
| Aug 17, 2026 | EFFECT | Filing |
| Aug 17, 2026 | EFFECT | Filing |
| Aug 06, 2026 | POS AM | Filing |
| Aug 06, 2026 | F-3/A | [Amend] Filing |
| Jul 31, 2026 | 3 | Filing |
| Jul 31, 2026 | SC 13D | Filing |
| Jul 27, 2026 | 20-F/A | [Amend] Filing |
| May 22, 2026 | POS AM | Filing |
Baird Medical Investment Limited
| Country | China |
| IPO Date | Dec 15, 2021 |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Employees | 146 |
| CEO | Haimei Wu |
Contact Details
Baide Building, Building 11 Guangzhou,
GD 510000 China
Stock Details
| Ticker Symbol | BDMD |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001982444 |
| CUSIP Number | G0705H103 |
| ISIN Number | KYG0705H1039 |
| SIC Code | 3841 |
Add to Watchlist
Select watchlists to add or remove BDMD